LRMR (STOCKS)
Larimar Therapeutics, Inc. Common Stock
$3.619700
+0.149700 (+4.31%)
Prev close: $3.470000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Carole S. Ben-Maimon
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $374.73M
- Employees
- 65
- P/E (TTM)
- -1.73
- P/B (TTM)
- 2.29
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.31 | $-0.55 | +0.2357 | +43.19% |
|
Dec 2025 (Q4)
|
$-0.73 | $-0.52 | -0.2129 | -41.17% |
|
Sep 2025 (Q3)
|
$-0.61 | $-0.41 | -0.1979 | -48.02% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.49 | +0.0798 | +16.29% |